Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
- PMID: 29046769
- PMCID: PMC5645582
- DOI: 10.4097/kjae.2017.70.5.500
Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
Erratum in
-
Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents.Korean J Anesthesiol. 2017 Dec;70(6):656. doi: 10.4097/kjae.2017.70.6.656. Epub 2017 Nov 14. Korean J Anesthesiol. 2017. PMID: 29226915 Free PMC article.
Abstract
Neuromuscular blockade plays an important role in the safe management of patient airways, surgical field improvement, and respiratory care. Rapid-sequence induction of anesthesia is indispensable to emergency surgery and obstetric anesthesia, and its purpose is to obtain a stable airway, adequate depth of anesthesia, and appropriate respiration within a short period of time without causing irritation or damage to the patient. There has been a continued search for new neuromuscular blocking drugs (NMBDs) with a rapid onset of action. Factors that affect the onset time include the potency of the NMBDs, the rate of NMBDs reaching the effect site, the onset time by dose control, metabolism and elimination of NMBDs, buffered diffusion to the effect site, nicotinic acetylcholine receptor subunit affinity, drugs that affect acetylcholine (ACh) production and release at the neuromuscular junction, drugs that inhibit plasma cholinesterase, presynaptic receptors responsible for ACh release at the neuromuscular junction, anesthetics or drugs that affect muscle contractility, site and methods for monitoring neuromuscular function, individual variability, and coexisting disease. NMBDs with rapid onset without major adverse events are expected in the next few years, and the development of lower potency NMBDs will continue. Anesthesiologists should be aware of the use of NMBDs in the management of anesthesia. The choice of NMBD and determination of the appropriate dosage to modulate neuromuscular blockade characteristics such as onset time and duration of neuromuscular blockade should be considered along with factors that affect the effects of the NMBDs. In this review, we discuss the factors that affect the onset time of NMBDs.
Keywords: Acetylcholine receptor; Anesthesia; Drug interactions; Neuromuscular junction; Neuromuscular monitoring; Non-depolarizing neuromuscular blocking agents; Onset time; Pharmacodynamics; Pharmacokinetics.
References
-
- Bevan DR. Fifty years of muscle relaxants. Acta Anaesthesiol Scand Suppl. 1995;106:2–6. - PubMed
-
- Moore EW, Hunter JM. The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth. 2001;87:912–925. - PubMed
-
- Bevan DR. Neuromuscular blocking drugs: onset and intubation. J Clin Anesth. 1997;9(6 Suppl):36S–39S. - PubMed
-
- Mahajan R. Is suxamethonium now obsolete? Curr Anaesth Crit Care. 1996;7:289–294.
-
- Tuba Z, Maho S, Vizi ES. Synthesis and structure-activity relationships of neuromuscular blocking agents. Curr Med Chem. 2002;9:1507–1536. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources